SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: khrnyc who wrote (1919)1/22/1998 9:40:00 AM
From: Tokyo VD  Read Replies (1) | Respond to of 7041
 
Keith,

You say that specific data on Zona's Vasomax is not yet available, but then you cite information from a meeting where the company's paid shill disclosed this very information.

I'm now convinced that you have other intentions and specifically those are to mislead people in this forum. Please tell us why you are doing this.

BTW, weren't you hired by an investment bank to discuss the merits of indinovir on a conf. call in the past year?

Tokyo



To: khrnyc who wrote (1919)1/23/1998 4:47:00 PM
From: Tunica Albuginea  Read Replies (1) | Respond to of 7041
 
Keith, I am sorry for responding late; busy; I note your reply.Comments:
-You did not answer my questions on fluid and drug distribution in the body.
-Can you reference the Vasomax data you gave me in an accepted Textbook or high quality mecicaal, peer reviewd, Journal?

TA


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News